{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:12:40Z","timestamp":1790662360671,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T00:00:00Z","timestamp":1240876800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1038\/sj.bjc.6605038","type":"journal-article","created":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T22:50:40Z","timestamp":1240959040000},"page":"1508-1512","source":"Crossref","is-referenced-by-count":41,"title":["Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband"],"prefix":"10.1038","volume":"100","author":[{"given":"J","family":"Gronwald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Cybulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Piesiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Suchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Huzarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Byrski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Gorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Debniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Szwiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Wokolowczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Matuszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lubinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S A","family":"Narod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,28]]},"reference":[{"key":"BF6605038_CR1","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/jnci\/94.16.1221","volume":"94","author":"CB Begg","year":"2002","unstructured":"Begg CB (2002) On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 94: 1221\u20131226","journal-title":"J Natl Cancer Inst"},{"key":"BF6605038_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/bcr2099","volume":"10","author":"GB Byrnes","year":"2008","unstructured":"Byrnes GB, Southey MC, Hopper JL (2008) Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories? Breast Cancer Res 10: 208","journal-title":"Breast Cancer Res"},{"key":"BF6605038_CR3","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1086\/421251","volume":"74","author":"CHEK2 Breast Cancer Case-Control Consortium","year":"2004","unstructured":"CHEK2 Breast Cancer Case-Control Consortium (2004) CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10\u2009860 breast cancer cases and 9065 controls from 10 studies. Am J Hum Genet 74: 1175\u20131182","journal-title":"Am J Hum Genet"},{"key":"BF6605038_CR4","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1086\/426403","volume":"75","author":"C Cybulski","year":"2004","unstructured":"Cybulski C, G\u00f3rski B, Huzarski T, oj\u00e6 B, Mierzejewski M, Debniak T, Teodorczyk U, Byrski T, Gronwald J, Matyjasik J, Zlowocka E, Lenner M, Grabowska E, Nej K, Castaneda J, Medrek K, ma\u00f1ska A, ma\u00f1ska J, Kurzawski G, Suchy J, Oszurek O, Witek A, Narod SA, i\u00f1ski J (2004a) CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genetic 75: 1131\u20131135","journal-title":"Am J Hum Genetic"},{"key":"BF6605038_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1158\/1055-9965.EPI-06-0566","volume":"16","author":"C Cybulski","year":"2007","unstructured":"Cybulski C, Gliniewicz B, Sikorski A, trok;adny J, Huzarski T, Gronwald J, Byrski T, Debniak T, Gorski B, Jakubowska A, Wokolorczyk D, Narod SA, Lubi\u00f1ski J (2007c) Epistatic relationship between the cancer susceptibility genes CHEK2 and p27. Cancer Epidemiol Biomarkers Prev 16: 572\u2013576","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6605038_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1399-0004.2008.01111.x","volume":"75","author":"C Cybulski","year":"2009","unstructured":"Cybulski C, Huzarski T, Byrski T, Gronwald J, Debniak T, Jakubowska A,, G\u00f3rski B,, o\u0142orczyk D, j\u00e6 B, Narod SA, \u00f1ski J . Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk. Clin Genet 2009; 75: 72\u201378","journal-title":"Clin Genet"},{"key":"BF6605038_CR7","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1158\/0008-5472.CAN-04-0341","volume":"64","author":"C Cybulski","year":"2004","unstructured":"Cybulski C, Huzarski T, G\u00f3rski B, oj\u00e6 B, Mierzejewski M, Debniak T, Gliniewicz B, Matyjasik J, strok;owocka E, Kurzawski G, Sikorski A, Posmyk M, Szwiec M, Czajka R, Narod SA, i\u00f1ski J (2004b) A novel founder CHEK2 mutation is associated with increased prostate cancer risk. Cancer Res 64: 2677\u20132679","journal-title":"Cancer Res"},{"key":"BF6605038_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10549-006-9320-y","volume":"102","author":"C Cybulski","year":"2007","unstructured":"Cybulski C, o\u0142orczyk D, Huzarski T, Byrski T, Gronwald J,, G\u00f3rski B,, Debniak T, oj\u00e6 B, Jakubowska A, van de Wetering T, Narod SA, i\u00f1ski J (2007a) A deletion in CHEK2 of 5395\u2009bp predisposes to breast cancer in Poland. Breast Cancer Res Treat 102: 119\u2013122","journal-title":"Breast Cancer Res Treat"},{"key":"BF6605038_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/sj.ejhg.5201734","volume":"15","author":"C Cybulski","year":"2007","unstructured":"Cybulski C, o\u0142orczyk D, strok;adny J, Kurzawski G, Suchy J, Grabowska E, Gronwald J, Huzarski T, Byrski T, G\u00f3rski B, D Ecedil Bniak T, Narod SA, i\u00f1ski J (2007b) Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations? Eur J Hum Genet 15: 237\u2013241","journal-title":"Eur J Hum Genet"},{"key":"BF6605038_CR10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/jmg.2005.036921","volume":"43","author":"J Gronwald","year":"2006","unstructured":"Gronwald J, Huzarski T, Byrski B, Medrek K, Menkiszak J, Monteiro AN, Sun P, Lubinski J, Narod SA (2006) Cancer risks in first-degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status. J Med Genet 43: 424\u2013428","journal-title":"J Med Genet"},{"key":"BF6605038_CR11","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1086\/302853","volume":"66","author":"R Moslehi","year":"2000","unstructured":"Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA (2000) BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet 66: 1259\u20131272","journal-title":"Am J Hum Genet"},{"key":"BF6605038_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1200\/JCO.2006.08.8229","volume":"25","author":"SA Narod","year":"2007","unstructured":"Narod SA, Lynch HT (2007) CHEK2 mutation and hereditary breast cancer. J Clin Oncol 25: 6\u20137","journal-title":"J Clin Oncol"},{"key":"BF6605038_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/jnci\/95.1.73-a","volume":"95","author":"HA Risch","year":"2003","unstructured":"Risch HA, Narod SA (2003) On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 95: 73\u201374","journal-title":"J Natl Cancer Inst"},{"key":"BF6605038_CR14","doi-asserted-by":"crossref","unstructured":"Serrano-Fern\u00e1ndez P, circ;bniak T, G\u00f3rski B, Bogdanova N, D\u00f6rk T, Cybulski C, Huzarski T, Byrski T, Gronwald J, o\u0142orczyk D, Narod SA, \u00f1ski J . Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk. Breast Cancer Res Treat 2008 [e-pub ahead of print]","DOI":"10.1007\/s10549-008-0249-1"},{"key":"BF6605038_CR15","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/jnci\/91.14.1241","volume":"91","author":"E Warner","year":"1999","unstructured":"Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet JS, Narod S (1999) Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91: 1241\u20131247","journal-title":"J Natl Cancer Inst"},{"key":"BF6605038_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1200\/JCO.2007.12.5922","volume":"26","author":"M Weischer","year":"2008","unstructured":"Weischer M, Bojesen SE, Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG (2008) CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26\u2009000 patient cases and 27\u2009000 controls. J Clin Oncol 26: 542\u2013548","journal-title":"J Clin Oncol"},{"key":"BF6605038_CR17","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1158\/0008-5472.CAN-07-5187","volume":"68","author":"S Zhang","year":"2008","unstructured":"Zhang S, Phelan CM, Zhang P, Rousseau F, Ghadirian P, Robidoux A, Foulkes W, Hamel N, McCready D, Trudeau M, Lynch H, Horsman D, De Matsuda ML, Aziz Z, Gomes M, Costa MM, Liede A, Poll A, Sun P, Narod SA (2008) Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study. Cancer Res 68: 2154\u20132157","journal-title":"Cancer Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605038.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605038","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605038.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:39:27Z","timestamp":1684413567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,28]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["BF6605038"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605038","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,28]]}}}